SYNBIOTIC SE is a leading European corporate group focused on the medical cannabis and industrial hemp markets. Committed to transparency and clarity, our Investor Relation Portal offers comprehensive insights, financial updates, and corporate developments for our shareholders.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
SYNBIOTIC SE is a leading European corporate group focused on the dynamic development of the medical cannabis and industrial hemp markets.
As a public listed company, SYNBIOTIC SE offers its investors the opportunity to capitalise on the strong growth potential of these highly regulated and rapidly expanding markets.
Our group strategically invests in promising ventures across the entire value chain – from cultivation and research to development, production, sales, and distribution of premium cannabinoid-based products. By integrating majority-owned companies, we ensure rigorous quality management throughout all production processes and the supply chain – a unique strength in the industry.
Through our successful buy-and-build strategy, we continuously expand our operations and strengthen our innovation-driven platform, setting new standards in the market.
SYNBIOTIC – Your Smartest Way to Invest in Medical Cannabis and Industrial Hemp.
joined our Platform
to fulfill our Vision
We unlock the power of cannabinoids to heal modern world diseases.
Annual General Meeting on August 05, 2021.
The Annual General Meeting of SynBiotic SE took place on Thursday, August 5, 2021, at 10:00 a.m. (CEST).
The Company's Annual General Meeting was held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).
Additional to Top 9:
There were no countermotions.
18. November 2020: Extraordinary General Meeting
The Extraordinary General Meeting of SynBiotic SE took place on Wednesday, November 18, 2020, at 12:00 noon ( CET).
July 2025: Financial calendar 2025 -Update
June 2025: Financial calendar 2025 -Update
December 2024: Data sheet Düsseldorf Stock Exchange
December 2024: Financial calendar 2024 -Update
November 2024: Company agreement - Satzung - SYNBIOTIC SE
July 2024: Financial calendar 2024 -Update
May 2024: Data sheet Düsseldorf Stock Exchange
May 2024: Financial calendar 2024 -Update
March 2024: Basic Information Sheet of the Convertible Bond March 2024
March 2024: Convertible Bond Conditions of the Convertible Bond March 2024/2025
Exercise declaration convertible bond: August 2023/2025 (ISIN DE000A351VJ4)
December 2023: Financial calendar 2024
August 2023: Securities Information Sheet- Update as of 25 August 2023
August 2023: Securities Information Sheet dated 20 August 2023
August 2023: Basic Information Sheet of the Convertible Bond August 2023/2025
August 2023: Convertible Bond Conditions of the Convertible Bond August 2023/2025
October 2021: Securities Information Sheet pursuant to § 4 of the German Securities Prospectus Act ("WpPG")
December 2020: Securities Prospectus
Meet us in person at premier hemp and cannabis exhibitions.
SynBiotic appears cautiously valued
SynBiotic appears cautiously valued
SynBiotic appears cautiously valued
When time meets opportunity; initiate with a BUY
SynBiotic appears cautiously valued
Strong founder and owner network that has proven how to scale a platformcompany
Strong founder and owner network that has proven how to scale a platformcompany
When time meets opportunity; initiate with a BUY
SynBiotic appears cautiously valued
Strong founder and owner network that has proven how to scale a platformcompany